In contrast, in vitro stimulation caused the 1.5-fold reduction in BTLA mRNA levels both in CLL patients and the controls; however, the changes seen in CLL were not significant (p = ns and p = 0.0132, respectively). This evidence concerns the gene BTLA and B-cell chronic lymphocytic leukemia.